Showing papers by "Robert Fagard published in 2015"
TL;DR: Little evidence is found that selection of a particular class of blood pressure-lowering drug will lead to substantially different outcomes for individuals who are obese compared with those who are lean.
42 citations
TL;DR: Autores/Miembros del Grupo de Trabajo: Stephan Windecker*, Philippe Kolh* (coordinador de la EACTS) (Bélgica), Fernando Alfonso (España), Jean-Philippe Collet (Francia), Jochen Cremer (Alemania), Volkmar Falk (Suiza), Gerasimos Filippatos (Grecia)
Abstract: Autores/Miembros del Grupo de Trabajo: Stephan Windecker* (coordinador de la ESC) (Suiza), Philippe Kolh* (coordinador de la EACTS) (Bélgica), Fernando Alfonso (España), Jean-Philippe Collet (Francia), Jochen Cremer (Alemania), Volkmar Falk (Suiza), Gerasimos Filippatos (Grecia), Christian Hamm (Alemania), Stuart J. Head (Países Bajos), Peter Jüni (Suiza), A. Pieter Kappetein (Países Bajos), Adnan Kastrati (Alemania), Juhani Knuuti (Finlandia), Ulf Landmesser (Suiza), Günther Laufer (Austria), Franz-Josef Neumann (Alemania), Dimitrios J. Richter (Grecia), Patrick Schauerte (Alemania), Miguel Sousa Uva (Portugal), Giulio G. Stefanini (Suiza), David Paul Taggart (Reino Unido), Lucia Torracca (Italia), Marco Valgimigli (Italia), William Wijns (Bélgica) y Adam Witkowski (Polonia)
39 citations
TL;DR: In patients with hypertension, increases in ambulatory, but not clinic, SBP predict higher risks for CVEs in women than in men, although women tended to have greater variability in SBP, this did not entirely explain the sex–ambulatory BP interactions.
Abstract: Background:Whether ambulatory blood pressure (BP) among hypertensive patients better predicts cardiovascular events (CVEs) in women relative to men is unclear.Methods:We searched PUBMED and OVID databases. Cohorts were required to have hypertension, 1+ years of follow-up, with stroke and coronary ar
22 citations
TL;DR: A meta-analysis confirmed absence of cohort differences with very similar combined results from the Georgia Cardiovascular Twin Study, indicating a large part of the heritability is explained by genes that specifically influence BP at night.
12 citations
TL;DR: The feasibility and quality of cardiovascular disease prevention and its affordability in subSaharan Africa, more specifically in Nigeria, is addressed and rates of awareness, treatment and blood pressure control are, in general, low.
Abstract: I n the current issue of the Journal, Hendriks et al. address the feasibility and quality of cardiovascular disease prevention [1] and its affordability [2] in subSaharan Africa, more specifically in Nigeria – the most populous country in the continent. These issues are important because of high prevalence and low awareness of hypertension, poor blood pressure control and high burden of blood pressure-related disease in these countries [3]. Kearney et al. [4] estimated the worldwide prevalence of hypertension, defined as blood pressure at least 140/ 90mmHg or use of antihypertensive medication, in adults aged 20 years and older, at 26.4% in the year 2000, with a projected increase to 29.2% in 2025. In 2000, the prevalence in sub-Saharan Africa amounted to 26.9% in men and 28.3% in women, with estimated prevalences of, respectively, 27.0 and 28.2% in 2025. Between 2000 and 2025, the number of adults with hypertension (in millions) would increase from 333 to 413 in economically developed countries and from 639 to 1150 in developing countries. In sub-Saharan Africa, the number of hypertensive patients would double from 79.8 to 150.6 million individuals. In a recent review and meta-analysis on the prevalence of hypertension in Nigeria, also published in the current issue of the Journal, Adeloy et al. [5] estimated an overall prevalence of 28.9% in 2010, 29.5% among men and 25.0% among women. As in most other developing countries, hypertension was more prevalent in urban areas (30.6%) than in rural areas (26.4%). It is of note that the awareness rate of hypertension in the Nigerian population was only 17.4%. In a recent review on hypertension in developing countries, Ibrahim and Damasceno [6] concluded that, whereas different national and regional surveys showed that hypertension is common in these countries, rates of awareness, treatment and blood pressure control are, in general, low. The low control rate can be attributed to a number of factors, such as high